submit to the journals

Multiple Sclerosis Journal Articles, Videos And Insights

Multiple Sclerosis: FEATURED Articles

flipper_slider

Multiple Sclerosis: Latest Articles

Multiple Sclerosis: INSIGHTS

The touchNEUROLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of neurology:

Insight
Highlights of the EAN Congress 2018 – focus on multiple sclerosis

Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK
Tim Sheldrick, Group Director and Advisory Editor, Touch Medical Media, UK
-Insights into multiple sclerosis presented at the 4th Congress of the European Academy of Neurology (EAN), Lisbon, Portugal, 16–19 June 2018

Insight
Highlights from the 70th Annual AAN Meeting 2018: focus on multiple sclerosis

Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK
Tim Sheldrick, Group Director and Advisory Editor, Touch Medical Media, UK

Insight
Smart devices in the management of multiple sclerosis

Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK

Interview
Interview with Sarah Sheikh, Senior Medical Director, Biogen, Cambridge, MA, US

Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK

Insight
No evident disease activity (NEDA) may become the new standard for disease control in multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Goring-On-Thames, Reading, UK

Multiple Sclerosis: FEATURED VIDEOS

Editor's choice

Cris Constantinescu (University of Nottingham, Queen's Medical Centre, UK), our Editor-in Chief of European Neurological Review, discusses the background and findings of his presentation comparing the immunomodulatory activity of mesenchymal stem cells from patients with secondary progressive multiple sclerosis (SPMS) and healthy volunteers against autologous immune cells (abstract available here). Study support: Multiple Sclerosis Society of Great Britain and Northern Ireland. Speaker disclosure: Cris Constantinescu has nothing to disclose in relation to this video interview. Filmed at the American Academy of Neurology (AAN) Annual Meeting 2018, Los Angeles, CA, US, April 2018.
Celia Oreja-Guevara (Vice Chair of Neurology and Head of Multiple Sclerosis Center, University Hospital San Carlos, and Professor of Neurology, University Complutense, Madrid, Spain) discusses the background and findings of her presentation entitled: Patient involvement in treatment decision-making: a sub-analysis of the ‘MS in the 21st Century international unmet needs survey’ comparing patient and healthcare professional perspectives. Questions 1. What is the ‘MS in the 21st Century’ initiative? (0:12) 2. What was the objective of the sub analysis that you’re presenting here at EAN? How were the data collected? (1:06) 3. What did the data reveal about approaches to treatment discussions and the factors that influence treatment decisions? (2:30) 4. What impact do you hope these findings will have on treatment decision-making in the future? (4:03) Speaker disclosure: Celia Oreja-Guevara has nothing to disclose in relation to this video interview. 'MS in the 21st Century' is a Merck KGaA, Darmstadt, Germany initiative involving healthcare professionals and patient advocates Filmed at the 4th Congress of the European Academy of Neurology (EAN), Lisbon, Portugal, June 2018.

Multiple Sclerosis: Latest Videos

Video List based on Category on Node Page

Latest Videos

Aksel Siva (EAN Programme Committee; Professor of Neurology, Istanbul University, Cerrahpasa School of Medicine, Turkey) talks to us about various treatment considerations in multiple sclerosis (MS): induction, individualised therapy, optimal therapeutic window and when to switch therapies. Part 2...
Aksel Siva (EAN Programme Committee; Professor of Neurology, Istanbul University, Cerrahpasa School of Medicine, Turkey) talks to us about various treatment considerations in multiple sclerosis (MS): induction, individualised therapy, optimal therapeutic window and when to switch therapies. Part 1...
Celia Oreja-Guevara (Vice Chair of Neurology and Head of Multiple Sclerosis Center, University Hospital San Carlos, and Professor of Neurology, University Complutense, Madrid, Spain) discusses the background and findings of her presentation entitled: Patient involvement in treatment...
David Hafler (Yale School of Medicine, CT) considers recent developments in understanding of genetic risk, as well as the roles of regulatory T cells and B cells in multiple sclerosis (MS), and shares his view on what he considers to be the most important therapeutic targets in MS and remaining...
Cris Constantinescu (University of Nottingham, Queen's Medical Centre, UK), our Editor-in Chief of European Neurological Review, discusses the background and findings of his presentation comparing the immunomodulatory activity of mesenchymal stem cells from patients with secondary progressive...
Mark Freedman (Ottawa Hospital and Ottawa Hospital Research Institute), a recent welcome addition to our editorial board for US Neurology, considers treatment biomarkers in multiple sclerosis including discussion around his presentation on neurofilament light chain (NF-L) levels before and after...

LATEST TWEETS

Conference Highlights